Header cover image

Australian (ASX) Pharma Industry Analysis

UpdatedMay 28, 2022
DataAggregated Company Financials
Companies40
  • 7D-2.2%
  • 3M-15.1%
  • 1Y-20.9%
  • YTD-28.5%

Over the last 7 days, the Pharma industry has dropped 2.2%, driven by Medical Developments International declining 16%. Overall the industry is down 21% in 12 months. Earnings are forecast to grow by 63% annually.

Industry Valuation and Performance

Has the Australian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022AU$3.9bAU$818.2m-AU$353,932,589.0014.2x
Mon, 25 Apr 2022AU$4.2bAU$800.9m-AU$348,637,558.0016.2x
Wed, 23 Mar 2022AU$4.4bAU$799.2m-AU$341,805,125.0017.6x
Fri, 18 Feb 2022AU$4.7bAU$749.0m-AU$464,190,190.0020.4x
Sun, 16 Jan 2022AU$5.0bAU$758.4m-AU$450,516,414.0021.3x
Tue, 14 Dec 2021AU$4.9bAU$758.4m-AU$450,516,414.0025.3x
Thu, 11 Nov 2021AU$4.9bAU$758.4m-AU$447,307,205.0024x
Sat, 09 Oct 2021AU$4.7bAU$753.7m-AU$446,965,453.0023.9x
Mon, 06 Sep 2021AU$4.7bAU$753.9m-AU$445,060,581.0021.9x
Wed, 04 Aug 2021AU$4.1bAU$752.8m-AU$442,004,016.0020.8x
Sat, 08 May 2021AU$4.8bAU$758.7m-AU$449,177,839.0012.3x
Tue, 09 Feb 2021AU$4.5bAU$759.6m-AU$478,696,362.0075.2x
Mon, 02 Nov 2020AU$3.7bAU$761.5m-AU$402,127,165.0021.2x
Thu, 06 Aug 2020AU$3.7bAU$773.8m-AU$314,501,632.0040.2x
Sun, 10 May 2020AU$3.8bAU$767.4m-AU$405,897,729.0045.5x
Sat, 01 Feb 2020AU$4.5bAU$773.8m-AU$489,584,699.0024.4x
Tue, 05 Nov 2019AU$4.3bAU$792.3m-AU$452,512,211.0024.7x
Fri, 09 Aug 2019AU$4.8bAU$809.9m-AU$422,273,520.0033x
Median PE Ratio

25.5x


Total Market Cap: AU$4.1bTotal Earnings: -AU$259,069,235.00Total Revenue: AU$784.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Pharma Industry Median PE3Y Average 29.7x202020212022
Current Industry PE
  • Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.2x which is lower than its 3-year average PE of 29.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Australian Pharma compare with similar industries?

AU Market-1.30%
Healthcare-1.59%
Pharma-2.18%
Pharma-2.18%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MYX Mayne Pharma GroupAU$0.291.7%
+AU$8.8m
-20.3%PS1.3x
CU6 Clarity PharmaceuticalsAU$0.437.4%
+AU$7.7m
n/aPS24x
IVX InvionAU$0.0138.3%
+AU$6.4m
-35.0%PS35.1x
EOF EcofibreAU$0.374.2%
+AU$5.0m
-32.7%PS4.2x
ILA Island PharmaceuticalsAU$0.2037.9%
+AU$4.5m
-50.0%PB2.8x
Simply Wall StÔäó
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

EMD

AU$0.28

Emyria

7D

-8.3%

1Y

25.0%

EOF

AU$0.37

Ecofibre

7D

4.2%

1Y

-32.7%

IVX

AU$0.013

Invion

7D

8.3%

1Y

-35.0%

CAN

AU$0.30

Cann Group

7D

-6.3%

1Y

-28.6%